Autolus Therapeutics PLC (NASDAQ:AUTL)

15.82
Delayed Data
As of Aug 10
 +0.16 / +1.02%
Today’s Change
3.00
Today|||52-Week Range
17.19
+19.85%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Autolus Therapeutics PLC have a median target of 25.50, with a high estimate of 50.00 and a low estimate of 13.00. The median estimate represents a +61.19% increase from the last price of 15.82.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Autolus Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.71
Sales
$303.0K
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.98%
 
 
 
 
 
 
Growthannually 6.17%
 
 
 

Sales

Growthquarterly 3.41%
 
 
 
 
 
 
Growthannually -57.28%
 
 
 
 
Key to the earnings and sales forecast charts.